Skip to main content
AB

Axolotl Biosciences

Axolotl Biosciences develops high-quality, xeno-free bioinks specifically engineered for 3D bioprinting human tissue models. Their technology ensures high cell viability post-printing and is compatible with multiple bioprinter platforms. This specialized material reduces time and labor costs for researchers working with fragile cell types in tissue engineering applications.

Founded 202092K+ followers
Updated 20 months ago

Funding

Funding not disclosed

IB
Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Creating functional 3D human tissue models for drug testing, toxicity screening, and regenerative medicine research is often hampered by challenges in maintaining high cell viability and managing labor costs associated with traditional bioinks and bioprinting processes. Current bioinks may lack the necessary biocompatibility and versatility to support a wide range of cell types and bioprinting platforms.

Solution

Axolotl Biosciences provides a suite of xeno-free bioinks and associated consulting services designed to streamline the creation of 3D tissue models. Their bioinks are formulated to be compatible with multiple bioprinting platforms, ensuring high cell viability post-printing, even when used with fragile cell types. By offering ready-to-use reagents and expert guidance, Axolotl Biosciences aims to reduce the time and labor required to develop functional human tissues, accelerating research in areas such as drug discovery and tissue engineering.

Target Audience

Axolotl Biosciences primarily serves researchers in tissue engineering, drug discovery, and regenerative medicine who require reliable and easy-to-use bioinks for creating 3D human tissue models.

Features

  • Xeno-free bioink formulations to minimize immune response and enhance biocompatibility.
  • Compatibility with a range of 3D bioprinting platforms, offering flexibility in experimental design.
  • Optimized for high cell viability post-printing, ensuring the creation of functional tissue models.
  • Designed for use with fragile cells, expanding the range of tissues that can be bioprinted.
  • Turn-key reagents that simplify the bioprinting workflow and reduce preparation time.
  • Consulting services to support researchers in optimizing their bioprinting protocols.
This profile is AI-generated and may contain inaccuracies.